MR immunization refers to the administration of a combined vaccine that protects against both measles and rubella. The MR vaccine is given to prevent both measles and rubella disease in children. It is a vital part of global health initiatives aimed at eliminating measles and controlling rubella, particularly congenital rubella syndrome (CRS). The MR vaccine is typically administered in two doses, with the first dose often given at 9 months of age and the second dose between 12 and 15 months.
The MR vaccine has proven to be highly effective in providing lifelong protection in most children. It is an important tool for preventing these potentially serious and debilitating diseases.
Benefits of MR immunization:
- Protects against measles and rubella: MR immunization provides immunity against both measles and rubella, protecting individuals from these highly contagious diseases.
- Prevents complications: Measles and rubella can lead to serious complications, such as pneumonia, encephalitis, and birth defects. MR immunization helps prevent these complications.
- Contributes to herd immunity: High vaccination coverage through MR immunization contributes to herd immunity, which protects those who cannot be vaccinated, such as infants and immunocompromised individuals.
Examples:
- The World Health Organization (WHO) recommends a 95% vaccination coverage rate with two doses of measles and rubella-containing vaccines within each district of each country.
- In Jordan, the MR vaccine has proven safe and effective, significantly contributing to the reduction of measles and rubella cases.
- The MR vaccine is used in outbreaks of measles or measles/rubella to control the spread of these diseases.
